|
|
Suppliers for
Sofosbuvir
|
Properties | CAS |
1190307-88-0 | Formula |
C22H29FN3O9P |
|
|
15 Registered suppliers
More details are to be found here
More details are to be found here
More details are to be found here
More details are to be found here
More details are to be found here
Molecular Formula: C22H29FN3O9P Molecular Weight: 529.4525242 HS Code: 29339900
Drug Category: HEPATITIS C Site: Virupaksha Organics Ltd
Drug Category: HEPATITIS C Site: Virupaksha Organics Ltd
Description : Sofosbuvir is a prodrug that is metabolized to the active antiviral agent 2'-deoxy-2'-α-fluoro-β-C-methyluridine-5'-monophosphate and is currently being investigated in phase 3 clinical trials for the treatment of hepatitis C. Studies have profiled sofosbuvir as a nucleotide inhibitor of hepatitis C virus, exerting selective inhibitory effects towards HCV NS5B polymerase. - Molecular Weight :529.45
- Purity :> 98%
Molecular Formula : C22H29FN3O9P Canonical SMILES : CC(C)OC(=O)C(C)NP(=O)(OCC1C(C(C(O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3 InChI : InChI=1S/C22H29FN3O9P/c1-13(2)33-19(29)14(3)25-36(31,35-15-8-6-5-7-9-15)32-12-16-18(28)22(4,23)20(34-16)26-11-10-17(27)24-21(26)30/h5-11,13-14,16,18,20,28H,12H2,1-4H3,(H,25,31)(H,24,27,30)/t14-,16+,18+,20+,22+,36-/m0/s1 InChIKey : TTZHDVOVKQGIBA-IQWMDFIBSA-N Solubility : Soluble in DMF, DMSO, Ethanol, PBS Appearance : White Solid Application : Antiviral Agents Storage : Store at -20°C Synonyms : PSI-7977; PSI 7977; PSI7977; GS7977; GS-7977; GS 7977; Sovaldi; N-[[P(S),2'R]-2'-deoxy-2'-fluoro-2'-methyl-P-phenyl-5'-uridylyl]-L-alanine, 1-methylethyl ester; Hepcinat; Hepcvir; Resof; SoviHep
More details are to be found here
Description : Sofosbuvir is a prodrug that is metabolized to the active antiviral agent 2'-deoxy-2'-α-fluoro-β-C-methyluridine-5'-monophosphate and is currently being investigated in phase 3 clinical trials for the treatment of hepatitis C. Studies have profiled sofosbuvir as a nucleotide inhibitor of hepatitis C virus, exerting selective inhibitory effects towards HCV NS5B polymerase. - Molecular Weight :529.45
- Purity :> 98%
Molecular Formula : C22H29FN3O9P Canonical SMILES : CC(C)OC(=O)C(C)NP(=O)(OCC1C(C(C(O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3 InChI : InChI=1S/C22H29FN3O9P/c1-13(2)33-19(29)14(3)25-36(31,35-15-8-6-5-7-9-15)32-12-16-18(28)22(4,23)20(34-16)26-11-10-17(27)24-21(26)30/h5-11,13-14,16,18,20,28H,12H2,1-4H3,(H,25,31)(H,24,27,30)/t14-,16+,18+,20+,22+,36-/m0/s1 InChIKey : TTZHDVOVKQGIBA-IQWMDFIBSA-N Solubility : Soluble in DMF, DMSO, Ethanol, PBS Appearance : White Solid Application : Antiviral Agents Storage : Store at -20°C Synonyms : PSI-7977; PSI 7977; PSI7977; GS7977; GS-7977; GS 7977; Sovaldi; N-[[P(S),2'R]-2'-deoxy-2'-fluoro-2'-methyl-P-phenyl-5'-uridylyl]-L-alanine, 1-methylethyl ester; Hepcinat; Hepcvir; Resof; SoviHep
More details are to be found here
Description : Sofosbuvir is a prodrug that is metabolized to the active antiviral agent 2'-deoxy-2'-α-fluoro-β-C-methyluridine-5'-monophosphate and is currently being investigated in phase 3 clinical trials for the treatment of hepatitis C. Studies have profiled sofosbuvir as a nucleotide inhibitor of hepatitis C virus, exerting selective inhibitory effects towards HCV NS5B polymerase. - Molecular Weight :529.45
- Purity :> 98%
Molecular Formula : C22H29FN3O9P Canonical SMILES : CC(C)OC(=O)C(C)NP(=O)(OCC1C(C(C(O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3 InChI : InChI=1S/C22H29FN3O9P/c1-13(2)33-19(29)14(3)25-36(31,35-15-8-6-5-7-9-15)32-12-16-18(28)22(4,23)20(34-16)26-11-10-17(27)24-21(26)30/h5-11,13-14,16,18,20,28H,12H2,1-4H3,(H,25,31)(H,24,27,30)/t14-,16+,18+,20+,22+,36-/m0/s1 InChIKey : TTZHDVOVKQGIBA-IQWMDFIBSA-N Solubility : Soluble in DMF, DMSO, Ethanol, PBS Appearance : White Solid Application : Antiviral Agents Storage : Store at -20°C Synonyms : PSI-7977; PSI 7977; PSI7977; GS7977; GS-7977; GS 7977; Sovaldi; N-[[P(S),2'R]-2'-deoxy-2'-fluoro-2'-methyl-P-phenyl-5'-uridylyl]-L-alanine, 1-methylethyl ester; Hepcinat; Hepcvir; Resof; SoviHep
More details are to be found here
Description : Sofosbuvir is a prodrug that is metabolized to the active antiviral agent 2'-deoxy-2'-α-fluoro-β-C-methyluridine-5'-monophosphate and is currently being investigated in phase 3 clinical trials for the treatment of hepatitis C. Studies have profiled sofosbuvir as a nucleotide inhibitor of hepatitis C virus, exerting selective inhibitory effects towards HCV NS5B polymerase. - Molecular Weight :529.45
- Purity :> 98%
Molecular Formula : C22H29FN3O9P Canonical SMILES : CC(C)OC(=O)C(C)NP(=O)(OCC1C(C(C(O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3 InChI : InChI=1S/C22H29FN3O9P/c1-13(2)33-19(29)14(3)25-36(31,35-15-8-6-5-7-9-15)32-12-16-18(28)22(4,23)20(34-16)26-11-10-17(27)24-21(26)30/h5-11,13-14,16,18,20,28H,12H2,1-4H3,(H,25,31)(H,24,27,30)/t14-,16+,18+,20+,22+,36-/m0/s1 InChIKey : TTZHDVOVKQGIBA-IQWMDFIBSA-N Solubility : Soluble in DMF, DMSO, Ethanol, PBS Appearance : White Solid Application : Antiviral Agents Storage : Store at -20°C Synonyms : PSI-7977; PSI 7977; PSI7977; GS7977; GS-7977; GS 7977; Sovaldi; N-[[P(S),2'R]-2'-deoxy-2'-fluoro-2'-methyl-P-phenyl-5'-uridylyl]-L-alanine, 1-methylethyl ester; Hepcinat; Hepcvir; Resof; SoviHep
More details are to be found here
Detailed information on the suppliers of
Sofosbuvir
|
Properties:
... more properties and specification on Sofosbuvir
|
|
Privileged suppliers
Last update 2024-04-30
|